Showing 1 - 3 results of 3 for search 'Inge Lefevre', query time: 0.02s Refine Results
  1. 1
    An open-label, Phase 3 trial of TAK-003, a live attenuated dengue tetravalent vaccine, in healthy US adults: immunogenicity and safety when administered during the second half of a 24-month shelf-life

    An open-label, Phase 3 trial of TAK-003, a live attenuated dengue tetravalent vaccine, in healthy US adults: immunogenicity and safety when administered during the second half of a... by Sanjay S. Patel, Peter Winkle, Alice Faccin, Francesco Nordio, Inge LeFevre, Claudia Galindo Tsoukas

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: A phase 3 randomized, controlled study.

    Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: A phase 3 randomized, contro... by Vianney Tricou, Brandon Essink, John E Ervin, Mark Turner, Ian Escudero, Martina Rauscher, Manja Brose, Inge Lefevre, Astrid Borkowski, Derek Wallace

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Immunogenicity and safety of a tetravalent dengue vaccine in dengue-naïve adolescents in Mexico City

    Immunogenicity and safety of a tetravalent dengue vaccine in dengue-naïve adolescents in Mexico City by Shibadas Biswal, Jorge Fernando Mendez Galvan, Mercedes Macias Parra, Juan-Francisco, Monica Belisa Carrascal Rodriguez, Esteban Patricio Rodriguez Bueno, Manja Brose, Martina Rauscher, Inge LeFevre, Derek Wallace, Astrid Borkowski

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: